Mitch Gold

ISI Group has published a research report on Dendreon (NYSE: DNDN) after the announcement that CEO Mitch Gold would be stepping down and replaced by John Johnson. In the report, ISI Group writes, "We believe the market will react well to this development and we look forward to understanding the...

Deutsche Bank has published a research report on Dendreon (NASDAQ: DNDN) after the announcement that CEO Mitch Gold is stepping down. In the report, Deutsche Bank writes, "New CEO John Johnson has history of M&A. Successfully sold ImClone to Eli Lilly & attempted to sell Savient. Our Take...

Dendreon Corp. (DNDN) CEO Mitch Gold was on CNBC this morning to discuss the success and prospects of Provenge, a cellular immunotherapy that stimulates a patient's immune system to target and attack prostate cancer. “We've been fighting the war on cancer for 40 years,” Gold said. However, Dendreon...